Norges Bank’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-9,773
Closed -$257K 2152
2020
Q2
$257K Buy
+9,773
New +$243K ﹤0.01% 2067
2020
Q1
Sell
-100,046
Closed -$2.48M 2065
2019
Q4
$2.48M Sell
100,046
-137,000
-58% -$3.18M ﹤0.01% 1966
2019
Q3
$5.06M Buy
237,046
+67,104
+39% +$1.84M ﹤0.01% 1914
2019
Q2
$5.4M Buy
+169,942
New +$5.33M ﹤0.01% 1924
2018
Q2
Sell
-33,131
Closed -$1.31M 2159
2018
Q1
$1.31M Hold
33,131
﹤0.01% 2040
2017
Q4
$1.11M Buy
33,131
+5,884
+22% +$209K ﹤0.01% 2052
2017
Q3
$1.01M Buy
27,247
+22,532
+478% +$846K ﹤0.01% 2058
2017
Q2
$175K Buy
+4,715
New +$154K ﹤0.01% 2112

Other funds holding PAHC

Norges Bank's PAHC Position: Q3 2020 in Review

Norges Bank sold out of Phibro Animal Health (PAHC) in Q3 2020, closing a stake of 9,773 shares — an estimated $257K sold.

Norges Bank first reported a position in PAHC in Q2 2017 and held it in 8 quarters. The position peaked at $5.4M in Q2 2019. 136 funds tracked by Wall St. Rank hold PAHC as of Q3 2020.

  • Norges Bank reported no remaining Phibro Animal Health position as of Q3 2020 after selling out during the quarter.
  • Norges Bank sold 9,773 Phibro Animal Health shares in Q3 2020, an estimated $257K.
  • Norges Bank first reported a position in Phibro Animal Health in Q2 2017 and held it in 8 quarters.
  • Norges Bank's Phibro Animal Health position peaked at $5.4M in Q2 2019.
  • 136 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2020.

Based on Norges Bank's 13F filing for Q3 2020, filed 10 Nov 2020.